Citigroup’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Sell |
161,561
-153,008
| -49% | -$418K | ﹤0.01% | 3003 |
|
|
2025
Q1 | $528K | Buy |
314,569
+47,059
| +18% | +$79.1K | ﹤0.01% | 2915 |
|
|
2024
Q4 | $436K | Buy |
267,510
+162,365
| +154% | +$265K | ﹤0.01% | 3113 |
|
|
2024
Q3 | $437K | Sell |
105,145
-250,183
| -70% | -$1.04M | ﹤0.01% | 3065 |
|
|
2024
Q2 | $1.94M | Sell |
355,328
-114,342
| -24% | -$624K | ﹤0.01% | 1782 |
|
|
2024
Q1 | $4.7M | Buy |
469,670
+279,770
| +147% | +$2.8M | ﹤0.01% | 1284 |
|
|
2023
Q4 | $775K | Buy |
189,900
+44,530
| +31% | +$182K | ﹤0.01% | 2367 |
|
|
2023
Q3 | $563K | Buy |
145,370
+13,616
| +10% | +$52.7K | ﹤0.01% | 2331 |
|
|
2023
Q2 | $785K | Sell |
131,754
-207,016
| -61% | -$1.23M | ﹤0.01% | 2410 |
|
|
2023
Q1 | $1.11M | Buy |
338,770
+99,251
| +41% | +$325K | ﹤0.01% | 1923 |
|
|
2022
Q4 | $946K | Sell |
239,519
-165,271
| -41% | -$653K | ﹤0.01% | 2050 |
|
|
2022
Q3 | $2.43M | Buy |
404,790
+10,540
| +3% | +$63.2K | ﹤0.01% | 1485 |
|
|
2022
Q2 | $2.54M | Buy |
394,250
+298,508
| +312% | +$1.92M | ﹤0.01% | 1444 |
|
|
2022
Q1 | $791K | Sell |
95,742
-95,521
| -50% | -$789K | ﹤0.01% | 2530 |
|
|
2021
Q4 | $2.96M | Buy |
191,263
+136,687
| +250% | +$2.12M | ﹤0.01% | 1663 |
|
|
2021
Q3 | $1.23M | Sell |
54,576
-95,630
| -64% | -$2.15M | ﹤0.01% | 2255 |
|
|
2021
Q2 | $2.95M | Buy |
150,206
+147,835
| +6,235% | +$2.91M | ﹤0.01% | 1819 |
|
|
2021
Q1 | $79K | Buy |
+2,371
| New | +$79K | ﹤0.01% | 3818 |
|